Randomized controlled trials evaluating the necessity of antimicrobial prophylaxis in colorectal endoscopic submucosal dissection

Randomized controlled trials evaluating the necessity of antimicrobial prophylaxis in colorectal endoscopic submucosal dissection - Necessity of antibiotics to colonic ESD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027982

Enrollment

160

Registered

2017-07-01

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

No administration of antibiotics during the perioperative period Intravenous administration of cefotiam(2.0g per day)for three days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Colorectal tumor meeting Japanese guidelines for colorectal cancer

Exclusion criteria

Exclusion criteria: 1)Patients taking oral steroids or immunosuppressants 2)Patients with an immunosuppressive disease(blood diseases, HIV etc.) 3)Patients with an allergy to Cefotiam 4)Patients deemed inapprorriate

Design outcomes

Primary

Measure	Time frame
postoperative fever	—

Countries

Japan

Contacts

Public ContactHiroya Sakaguchi

Kobe University Gastroenterology

skgch@med.kobe-u.ac.jp078-382-6305

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026